IL153241A0 - Powder compositions - Google Patents

Powder compositions

Info

Publication number: IL153241A0
Authority: IL; Israel
Prior art keywords: powder compositions; compositions; powder
Prior art date: 2000-06-08

Application number

IL15324101A

Original Assignee

Powderject Vaccines Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-08

Filing date

2001-06-08

Publication date

2003-07-06

2001-06-08 Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc

2003-07-06 Publication of IL153241A0 publication Critical patent/IL153241A0/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

IL15324101A 2000-06-08 2001-06-08 Powder compositions IL153241A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US21058100P	2000-06-08	2000-06-08
US59077700A	2000-06-08	2000-06-08
PCT/US2001/018494 WO2001093829A2 (en)	2000-06-08	2001-06-08	Powder compositions

Publications (1)

Publication Number	Publication Date
IL153241A0 true IL153241A0 (en)	2003-07-06

Family

ID=26905296

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15324101A IL153241A0 (en)	2000-06-08	2001-06-08	Powder compositions

Country Status (11)

Country	Link
EP (1)	EP1289494A2 (en)
JP (1)	JP2003535119A (en)
KR (1)	KR20030020294A (en)
CN (1)	CN1438874A (en)
AU (1)	AU2001275371B9 (en)
BR (1)	BR0111494A (en)
CA (1)	CA2412197A1 (en)
IL (1)	IL153241A0 (en)
MX (1)	MXPA02012039A (en)
NZ (2)	NZ552576A (en)
WO (1)	WO2001093829A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1399131A2 (en)	2001-06-08	2004-03-24	Powderject Vaccines, Inc.	Spray freeze-dried compositions
KR20050044523A (en) *	2001-11-19	2005-05-12	벡톤 디킨슨 앤드 컴퍼니	Pharmaceutical compositions in particulate form
AU2003234090A1 (en)	2002-04-11	2003-10-27	Medimmune Vaccines, Inc.	Spray freeze dry of compositions for pulmonary administration
DE10339197A1 (en) *	2003-08-22	2005-03-24	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Spray-dried amorphous powder with low residual moisture and good storage stability
MX2007003726A (en) *	2004-09-28	2007-06-15	Johnson & Johnson	Stabilization of alum-adjuvanted immunologically active agents.
AU2006261669B2 (en) *	2005-06-27	2011-07-07	Applied Thin Films, Inc.	Aluminum phosphate based microspheres
KR20080059289A (en)	2005-10-04	2008-06-26	알크-아벨로 에이/에스	Solid vaccine formulation
WO2007053781A2 (en) *	2005-11-01	2007-05-10	Novartis Ag	Compositions with antigens adsorbed to calcium phosphate
EP2068834A2 (en) *	2006-09-08	2009-06-17	Becton, Dickinson & Company	Stable powder formulations of aluma-dsorbed vaccines
EP3590503A1 (en)	2006-10-12	2020-01-08	The University of Queensland	Compositions and methods for modulating immune responses
DK2829282T3 (en) *	2007-03-22	2018-01-02	Univ Colorado Regents	Process for preparing an immunologically active adjuvant-linked dried vaccine composition
KR101540920B1 (en) *	2007-07-26	2015-08-03	사노피 파스퇴르 리미티드	Antigen-adjuvant compositions and methods
EP2589392B1 (en)	2008-03-05	2016-11-30	Sanofi Pasteur	Process for stabilizing an adjuvant containing vaccine composition
US9616117B2 (en)	2008-10-02	2017-04-11	Pharmathene, Inc.	Anthrax vaccine formulation and uses thereof
JP5960120B2 (en)	2010-03-31	2016-08-02	スタビリテックリミテッド	Stabilization of virus particles
EP2552478B1 (en)	2010-03-31	2016-12-21	Stabilitech Ltd.	Excipients for stabilising viral particles
GB2499480A (en) *	2010-03-31	2013-08-21	Stabilitech Ltd	Method for preserving alum adjuvants and alum-adjuvanted vaccines
DK2635596T3 (en)	2010-11-01	2019-11-25	Univ Sydney Technology	IMMUN MODULATORS AND USES THEREOF
AU2011336410B2 (en)	2010-12-02	2015-01-22	Oncolytics Biotech Inc.	Lyophilized viral formulations
WO2012075379A2 (en)	2010-12-02	2012-06-07	Oncolytics Biotech Inc.	Liquid viral formulations
CN102133396B (en) *	2011-03-16	2013-10-16	中国人民解放军第三〇二医院	Vaccine injection and preparation method thereof
GB201117233D0 (en)	2011-10-05	2011-11-16	Stabilitech Ltd	Stabilisation of polypeptides
AU2013228096B2 (en) *	2012-03-05	2017-07-13	Intravacc B.V.	Methods and compositions for stabilizing dried biological materials
KR101441539B1 (en) *	2013-04-01	2014-09-18	재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소	Adhesive compositions having improved hygroscopicity and preparation methods thereof
CN103641886B (en) *	2013-11-26	2015-07-29	精晶药业股份有限公司	A kind of process for purification of glutamine dipeptide
GB201406569D0 (en)	2014-04-11	2014-05-28	Stabilitech Ltd	Vaccine compositions
GB2562241B (en)	2017-05-08	2022-04-06	Stabilitech Biopharma Ltd	Vaccine compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2505657A1 (en) *	1981-05-13	1982-11-19	Pasteur Institut	IMPROVEMENTS IN LIVE STABILIZING AGENTS FOR THE PREPARATION OF VACCINES, AND STABILIZED VACCINES CONTAINING SAID STABILIZING AGENTS
HU188847B (en) *	1983-02-22	1986-05-28	Human Oltoanyagtermeloe Es Kutato Intezet,Hu	Process for producing liophylized combined vaccines
JPS6013718A (en) *	1983-07-05	1985-01-24	Chemo Sero Therapeut Res Inst	B-type hepatitis vaccine
WO1994015363A1 (en) *	1992-12-28	1994-07-07	Yu Shih Chiang	Non-volatile semiconductor memory cell
JP3583128B2 (en) *	1993-01-08	2004-10-27	シーエスエル、リミテッド	Vaccine preparation
TW404844B (en) *	1993-04-08	2000-09-11	Oxford Biosciences Ltd	Needleless syringe
US5902565A (en) *	1993-12-24	1999-05-11	Csl Limited	Spray dried vaccine preparation comprising aluminium adsorbed immunogens
RU2096042C1 (en) *	1996-11-06	1997-11-20	Виктор Иванович Ситьков	Method of preparing multipartial vaccine for leptospirosis control in animals
AU756828B2 (en) *	1997-12-02	2003-01-23	Powderject Vaccines, Inc.	Transdermal delivery of particulate vaccine compositions

2001
- 2001-06-08 KR KR1020027016801A patent/KR20030020294A/en not_active Application Discontinuation
- 2001-06-08 NZ NZ552576A patent/NZ552576A/en unknown
- 2001-06-08 MX MXPA02012039A patent/MXPA02012039A/en active IP Right Grant
- 2001-06-08 NZ NZ523103A patent/NZ523103A/en unknown
- 2001-06-08 IL IL15324101A patent/IL153241A0/en unknown
- 2001-06-08 BR BR0111494-8A patent/BR0111494A/en not_active Application Discontinuation
- 2001-06-08 AU AU2001275371A patent/AU2001275371B9/en not_active Ceased
- 2001-06-08 CN CN01811745A patent/CN1438874A/en active Pending
- 2001-06-08 WO PCT/US2001/018494 patent/WO2001093829A2/en active IP Right Grant
- 2001-06-08 CA CA002412197A patent/CA2412197A1/en not_active Abandoned
- 2001-06-08 JP JP2002501402A patent/JP2003535119A/en active Pending
- 2001-06-08 EP EP01942075A patent/EP1289494A2/en not_active Withdrawn

Also Published As

Publication number	Publication date
CA2412197A1 (en)	2001-12-13
WO2001093829A2 (en)	2001-12-13
AU2001275371B9 (en)	2007-06-07
EP1289494A2 (en)	2003-03-12
BR0111494A (en)	2004-01-13
MXPA02012039A (en)	2003-06-06
WO2001093829A3 (en)	2002-06-13
NZ523103A (en)	2005-08-26
JP2003535119A (en)	2003-11-25
KR20030020294A (en)	2003-03-08
AU2001275371B2 (en)	2006-12-21
AU7537101A (en)	2001-12-17
NZ552576A (en)	2008-06-30
CN1438874A (en)	2003-08-27

Publication	Publication Date	Title
AU7537101A (en)	2001-12-17	Powder compositions
GB0010227D0 (en)	2000-06-14	Pouched compositions
GB0010249D0 (en)	2000-06-14	Pouched compositions
EP1341554A4 (en)	2005-06-15	Colostrum-based composition
GB0011084D0 (en)	2000-06-28	Cosmetic compositions
GB0016937D0 (en)	2000-08-30	Antiperspirant compositions
EP1320385A4 (en)	2004-11-10	Combination compositions
GB0022667D0 (en)	2000-11-01	Pouched compositions
EP1270611A4 (en)	2004-09-08	Composition
GB0019651D0 (en)	2000-09-27	Compositions
GB2376022B (en)	2003-12-10	Powder coating compositions
GB0025439D0 (en)	2000-11-29	Cosmetic compositions
GB0016067D0 (en)	2000-08-23	Oral compositions
EP1269969A4 (en)	2003-10-08	Cosmetic compositions
AU2001287852A8 (en)	2007-12-20	Composition
GB2376021B (en)	2003-09-24	Powder coating compositions
GB0004518D0 (en)	2000-04-19	Compositions
GB2372518B (en)	2003-04-16	Powder composition
GB0022297D0 (en)	2000-10-25	Oral compositions
HK1077767A1 (en)	2006-02-24	Deodorant compositions
EP1267814A4 (en)	2003-07-09	Composition
GB0031267D0 (en)	2001-01-31	Novel compositions
GB0004522D0 (en)	2000-04-19	Compositions
GB0013615D0 (en)	2000-07-26	Compositions
GB0001854D0 (en)	2000-03-22	Compositions